UPDATE : Thursday, May 23, 2019
[News Focus] Kolon, regulator rapped for not doing enough to quell concerns of patients by Jeong Sae-im 2019-05-22 11:59
Legislator, activists call for revoking Invossa license, conducting probes by Jeong Sae-im 2019-05-21 16:03
[Reporter’s Notebook] ‘Wanna know what’s going on with MSD Korea?’ by Jeong Sae-im 2019-05-21 11:44
Kolon to follow 3,700 Invossa-treated patients for 15 years by Jeong Sae-im 2019-05-17 15:38
Will Celltrion CEO’s bet on ‘bio valley’ pay off? by Jeong Sae-im 2019-05-17 13:21
CHA Biotech’s operating income plunges 92% in Q1 by Jeong Sae-im 2019-05-16 13:41
KangStem Biotech completes stem cell drug plant by Jeong Sae-im 2019-05-16 11:27
Samsung BioLogics in tight spot amid probe, shareholders’ lawsuit by Jeong Sae-im 2019-05-14 14:10
‘MSD Korea’s foreign exec got drunk, sexually harassed female worker’ by Jeong Sae-im 2019-05-14 11:53
Celltrion’s operating income down 33% in Q1 by Jeong Sae-im 2019-05-09 15:26
If Invossa license gets revoked, Kolon should return $13 million to Mundipharma by Jeong Sae-im 2019-05-08 15:33
Mobile healthcare firm Noom raises $58 million for biz expansion by Jeong Sae-im 2019-05-08 15:23
Inspection will clear all suspicions over Invossa: TissueGene by Jeong Sae-im 2019-05-08 14:32
Kolon might have covered up Invossa mislabeling for 2 years by Jeong Sae-im 2019-05-07 15:55
[Exclusive] MSD workers appalled by executive’s remarks on childcare leave by Jeong Sae-im 2019-05-07 12:08
Civic group files complaint against Kolon, regulator by Jeong Sae-im 2019-04-30 14:59
Techniques for biobetters get ever more advanced by Jeong Sae-im 2019-04-29 11:48
‘Invossa scandal might be more far-reaching’ by Jeong Sae-im 2019-04-26 18:08
Foreign patients to join class-action suit against Kolon for Invossa by Jeong Sae-im 2019-04-25 15:39
Samsung Biologics logs ₩23.4 billion operating loss in Q1 by Jeong Sae-im 2019-04-25 12:08
Back to Top